CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Millions	Total	Common Stock	Capital in Excess of Par Value	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance at Dec. 31, 2023	$ 4,113	$ 1	$ 695	$ (819)	$ (299)	$ 4,535
Beginning balance (in shares) at Dec. 31, 2023		126,090,000.000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(132)					(132)
Other comprehensive income	5				5
Common stock repurchase (in shares)		(561,000)
Common stock repurchase	(21)			(21)
Stock-based compensation	15		15
Stock issued under stock plans (in shares)		177,000
Stock issued under stock plans	(3)		(3)
Ending balance at Mar. 31, 2024	3,977	$ 1	707	(840)	(294)	4,403
Ending balance (in shares) at Mar. 31, 2024		125,706,000
Beginning balance at Dec. 31, 2023	4,113	$ 1	695	(819)	(299)	4,535
Beginning balance (in shares) at Dec. 31, 2023		126,090,000.000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	88
Other comprehensive income	12
Ending balance at Jun. 30, 2024	4,226	$ 1	757	(868)	(287)	4,623
Ending balance (in shares) at Jun. 30, 2024		126,475,000
Beginning balance at Mar. 31, 2024	3,977	$ 1	707	(840)	(294)	4,403
Beginning balance (in shares) at Mar. 31, 2024		125,706,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	220					220
Other comprehensive income	7				7
Common stock repurchase (in shares)		(663,000)
Common stock repurchase	(28)			(28)
Stock-based compensation (in shares)		13,000.000
Stock-based compensation	13		13
Stock issued for employee stock purchase plan (in shares)		1,401,000
Stock issued for employee stock purchase plan	37		37
Stock issued under stock plans (in shares)		18,000.000
Stock issued under stock plans	0		0
Ending balance at Jun. 30, 2024	4,226	$ 1	757	(868)	(287)	4,623
Ending balance (in shares) at Jun. 30, 2024		126,475,000
Beginning balance at Dec. 31, 2024	$ 4,372	$ 1	811	(1,131)	(239)	4,930
Beginning balance (in shares) at Dec. 31, 2024	123,119,199	123,119,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (166)					(166)
Other comprehensive income	5				5
Common stock repurchase (in shares)		(1,766,000)
Common stock repurchase	(107)			(107)
Stock-based compensation (in shares)		5,000.000
Stock-based compensation	22		22
CARES Act warrants exercised		810,000
Stock issued under stock plans (in shares)		717,000
Stock issued under stock plans	11		11
Ending balance at Mar. 31, 2025	4,137	$ 1	844	(1,238)	(234)	4,764
Ending balance (in shares) at Mar. 31, 2025		122,885,000
Beginning balance at Dec. 31, 2024	$ 4,372	$ 1	811	(1,131)	(239)	4,930
Beginning balance (in shares) at Dec. 31, 2024	123,119,199	123,119,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 6
Other comprehensive income	11
Ending balance at Jun. 30, 2025	$ 3,942	$ 1	899	(1,666)	(228)	4,936
Ending balance (in shares) at Jun. 30, 2025	115,276,005	115,276,000
Beginning balance at Mar. 31, 2025	$ 4,137	$ 1	844	(1,238)	(234)	4,764
Beginning balance (in shares) at Mar. 31, 2025		122,885,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	172					172
Other comprehensive income	6				6
Common stock repurchase (in shares)		(8,721,000)
Common stock repurchase	(428)			(428)
Stock-based compensation (in shares)		9,000.000
Stock-based compensation	17		17
Stock issued for employee stock purchase plan (in shares)		1,023,000.000
Stock issued for employee stock purchase plan	39		39
Stock issued under stock plans (in shares)		80,000.000
Stock issued under stock plans	(1)		(1)
Ending balance at Jun. 30, 2025	$ 3,942	$ 1	$ 899	$ (1,666)	$ (228)	$ 4,936
Ending balance (in shares) at Jun. 30, 2025	115,276,005	115,276,000